Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias

The burden of atherosclerotic disease worldwide necessitates implementing the treatment of its risk factors. Among them, hypercholesterolemia has a central role. In addition to conventional small organic compounds and the recently introduced monoclonal antibodies, new technologies are arising such a...

Full description

Bibliographic Details
Main Authors: Clarice Gareri, Alberto Polimeni, Salvatore Giordano, Laura Tammè, Antonio Curcio, Ciro Indolfi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
hypercholesterolemia
miRNA
ASO
siRNAF
Online Access:https://www.mdpi.com/2077-0383/11/13/3884

Similar Items

Similar Items